Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:2049-2053
Published online before print October 10, 2002, doi: 10.1161/01.ATV.0000040598.18570.54
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
22/12/2049    most recent
01.ATV.0000040598.18570.54v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rikitake, Y.
Right arrow Articles by Yokoyama, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rikitake, Y.
Right arrow Articles by Yokoyama, M.
Related Collections
Right arrow Pathophysiology
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:2049.)
© 2002 American Heart Association, Inc.


Atherosclerosis

Expression of G2A, a Receptor for Lysophosphatidylcholine, by Macrophages in Murine, Rabbit, and Human Atherosclerotic Plaques

Yoshiyuki Rikitake; Ken-ichi Hirata; Tomoya Yamashita; Kenji Iwai; Seiichi Kobayashi; Hiroshi Itoh; Masanori Ozaki; Junya Ejiri; Masashi Shiomi; Nobutaka Inoue; Seinosuke Kawashima; Mitsuhiro Yokoyama

From the Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine (Y.R., K.H., T.Y., K.I., M.O., J.E., N.I., S. Kawashima, M.Y.) and Department of Surgical Pathology (S. Kobayashi, H.I.), Kobe University Graduate School of Medicine, and the Institute for Experimental Animals (M.S.), Kobe University School of Medicine, Kobe, Japan.

Correspondence to Mitsuhiro Yokoyama, MD, PhD, Professor, Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. E-mail yokoyama{at}med.kobe-u.ac.jp

Abstract

Objective— Lysophosphatidylcholine (LPC), a major phospholipid component of oxidized low density lipoprotein, has been demonstrated to induce multiple functional alterations of vasculature that are potentially involved in atherosclerosis. Recently, an orphan G-protein-coupled receptor, G2A, has been identified as a high-affinity receptor for LPC. Although it has been demonstrated that G2A is expressed predominantly in lymphoid tissues and lymphocytes, there are no reports to determine whether G2A is expressed in atherosclerotic lesions and cardiovascular cells.

Methods and Results— Immunohistochemistry with an anti-G2A antibody revealed that G2A was expressed predominantly by macrophages within atherosclerotic lesions at the aortic root of apolipoprotein E-deficient mice and the thoracic aortas of Watanabe heritable hyperlipidemic rabbits. In atherosclerotic plaques of human coronary arterial specimens, G2A was expressed by macrophages within the lipid-rich plaques, whereas no immunoreactivity of G2A was observed in fibrous plaques where macrophages did not exist. Reverse transcription-polymerase chain reaction analysis demonstrated that G2A mRNA was highly expressed in human and murine monocytes/macrophages. The expression of G2A protein was detected in human and murine monocytes/macrophages by immunoblotting.

Conclusions— These findings demonstrate that monocytes/macrophages abundantly express G2A and suggest that G2A may play a role in the formation and progression of atherosclerotic lesions.


Key Words: atherosclerosis • lipids • plaque • receptors




This article has been cited by other articles:


Home page
Circ. Res.Home page
D. T. Bolick, M. D. Skaflen, L. E. Johnson, S.-C. Kwon, D. Howatt, A. Daugherty, K. S. Ravichandran, and C. C. Hedrick
G2A Deficiency in Mice Promotes Macrophage Activation and Atherosclerosis
Circ. Res., February 13, 2009; 104(3): 318 - 327.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. K. Jackson, W. Abate, J. Parton, S. Jones, and J. L. Harwood
Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response
J. Leukoc. Biol., July 1, 2008; 84(1): 86 - 92.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. T. Bolick, A. M. Whetzel, M. Skaflen, T. L. Deem, J. Lee, and C. C. Hedrick
Absence of the G Protein-Coupled Receptor G2A in Mice Promotes Monocyte/Endothelial Interactions in Aorta
Circ. Res., March 2, 2007; 100(4): 572 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Qiu, A. C. Ho, W. Yu, and J. S. Hill
Suppression of endothelial or lipoprotein lipase in THP-1 macrophages attenuates proinflammatory cytokine secretion
J. Lipid Res., February 1, 2007; 48(2): 385 - 394.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Fujita, M. Yoshizumi, Y. Izawa, N. Ali, H. Ohnishi, Y. Kanematsu, K. Ishizawa, K. Tsuchiya, and T. Tamaki
Transactivation of Fetal Liver Kinase-1/Kinase-Insert Domain-Containing Receptor by Lysophosphatidylcholine Induces Vascular Endothelial Cell Proliferation
Endocrinology, March 1, 2006; 147(3): 1377 - 1385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Obinata, T. Hattori, S. Nakane, K. Tatei, and T. Izumi
Identification of 9-Hydroxyoctadecadienoic Acid and Other Oxidized Free Fatty Acids as Ligands of the G Protein-coupled Receptor G2A
J. Biol. Chem., December 9, 2005; 280(49): 40676 - 40683.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Zalewski and C. Macphee
Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis: Biology, Epidemiology, and Possible Therapeutic Target
Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 923 - 931.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. V. Yang, C. G. Radu, L. Wang, M. Riedinger, and O. N. Witte
Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A
Blood, February 1, 2005; 105(3): 1127 - 1134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Murakami, T. Yokomizo, T. Okuno, and T. Shimizu
G2A Is a Proton-sensing G-protein-coupled Receptor Antagonized by Lysophosphatidylcholine
J. Biol. Chem., October 8, 2004; 279(41): 42484 - 42491.
[Abstract] [Full Text] [PDF]